UTHR
United Therapeutics Corporation · Healthcare · Biotechnology
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q2 2024
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 159 | +4 | 28.21M | $15.29B | +8 | −3 |
| Q1 2026 | 157 | -1 | 29.64M | $17.54B | +5 | −7 |
| Q4 2025 | 157 | +1 | 32.29M | $15.72B | +2 | — |
| Q3 2025 | 21 | 0 | 20.11M | $8.43B | +1 | −2 |
| Q2 2025 | 19 | 0 | 20.17M | $5.79B | — | — |
| Q1 2025 | 16 | +1 | 10.14M | $3.12B | +1 | — |
| Q4 2024 | 15 | 0 | 10.52M | $3.71B | +1 | −1 |
| Q3 2024 | 14 | 0 | 8.99M | $3.22B | — | — |
| Q2 2024 | 14 | — | 8.17M | $2.60B | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 3.29M | — | $1.05B | 0.2% | n/c | 1 | SEC ↗ |
| 2 | Wellington Management ✦ | 3.29M | — | $1.05B | 0.2% | n/c | 1 | SEC ↗ |
| 3 | Wellington Management ✦ | 3.29M | — | $1.05B | 0.2% | n/c | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 3.29M | — | $1.05B | 0.2% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 3.29M | — | $1.05B | 0.2% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 3.29M | — | $1.05B | 0.2% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 3.29M | — | $1.05B | 0.2% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 3.29M | — | $1.05B | 0.2% | n/c | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 3.29M | — | $1.05B | 0.2% | n/c | 1 | SEC ↗ |
| 10 | Renaissance Technologies ✦ | 2.17M | — | $692.75M | 1.2% | n/c | 1 | SEC ↗ |
| 11 | Geode Capital Management ✦ (pasif) | 1.05M | — | $333.57M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Geode Capital Management ✦ (pasif) | 1.05M | — | $333.57M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 719.51K | — | $229.20M | 0.4% | n/c | 1 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 719.51K | — | $229.20M | 0.4% | n/c | 1 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 719.51K | — | $229.20M | 0.4% | n/c | 1 | SEC ↗ |
| 16 | Arrowstreet Capital ✦ | 438.68K | — | $139.74M | 0.1% | n/c | 1 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 234.92K | — | $74.83M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | T. Rowe Price ✦ | 234.92K | — | $74.83M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Millennium Management ✦ | 103.03K | — | $32.82M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Gotham Asset Management ✦ | 47.59K | — | $15.16M | 0.2% | n/c | 1 | SEC ↗ |
| 21 | D. E. Shaw & Co. ✦ | 42.02K | — | $13.39M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | D. E. Shaw & Co. ✦ | 42.02K | — | $13.39M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Norges Bank ✦ (pasif) | 38.93K | — | $12.40M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Marshall Wace ✦ | 20.11K | — | $6.40M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Bridgewater Associates ✦ | 12.75K | — | $4.06M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Fisher Asset Management ✦ | 5.16K | — | $1.64M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Two Sigma Investments ✦ | 1.90K | — | $605,245 | 0.0% | n/c | 1 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 1 pemegang, 218.70K saham, $129,684 dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer, Director · 1.32K lbr · $675,421
Officer, Director · 3.59K lbr · $1.84M
Officer, Director · 224 lbr · $114,108
Officer, Director · 3.06K lbr · $1.56M
Officer, Director · 1.30K lbr · $669,921
Officer, Director · 773 lbr · $399,695
Officer, Director · 235 lbr · $123,474
Officer, Director · 455 lbr · $238,247
Officer, Director · 669 lbr · $349,411
Officer, Director · 271 lbr · $139,254
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi